Ionis Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
Ionis Pharmaceuticals, Inc. (IONS) reported Adjustments to Additional Paid in Capital, Other of -$136.62 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-02-21.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-02-21
- Ionis Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-12-31 was $0.00.
- Ionis Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-09-30 was $0.00.
- Ionis Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2021-06-30 was -$136.62M.
- Ionis Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2021 was -$136.62M.
- Ionis Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2019 was -$85.86M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $0.00 derived: sum of 2 quarters · filed 2024-02-21 | -$136.62M derived: sum of 3 quarters · filed 2024-02-21 | -$136.62M 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | -$136.62M derived: sum of 2 quarters · filed 2022-11-09 | -$136.62M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$136.62M 10-Q · filed 2022-08-09 | -$136.62M 10-Q · filed 2022-08-09 | ||
| 2019-12-31 | -$85.86M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |